See more : Grifols, S.A. (GRFS) Income Statement Analysis – Financial Results
Complete financial analysis of The China Fund, Inc. (CHN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The China Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Shaanxi Xinghua Chemistry Co.,Ltd (002109.SZ) Income Statement Analysis – Financial Results
- Dongil Industries Co.,Ltd. (004890.KS) Income Statement Analysis – Financial Results
- Arras Minerals Corp. (ARK.V) Income Statement Analysis – Financial Results
- Pidilite Industries Limited (PIDILITIND.BO) Income Statement Analysis – Financial Results
- Fino Payments Bank Limited (FINOPB.NS) Income Statement Analysis – Financial Results
The China Fund, Inc. (CHN)
About The China Fund, Inc.
The China Fund, Inc. is a closed ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. It invests in the public equity markets of China that includes the People's Republic of China, Hong Kong, and Taiwan. The fund invests in stocks of companies operating across diversified sectors. It employs a combination of fundamental analysis with bottom-up approach and quantitative analysis to create its portfolio. The fund seeks to benchmarks the performance of its portfolio against the MSCI Golden Dragon Index. The China Fund, Inc. was formed on April 28, 1992 and is domiciled in the United States.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.21M | 11.22M | -117.47M | 12.36M | 106.61M | 59.00M | -54.89M | 81.15M | -23.44M | 8.62M | 10.01M | 11.62M | 13.20M | 13.86M | 12.70M | 12.86M | 16.41M | 10.79M | 9.47M | 7.04M | 5.85M | 4.11M |
| Cost of Revenue | 0.00 | 0.00 | 1.62M | 2.71M | 2.19M | 2.61M | 3.66M | 3.21M | 2.90M | 3.16M | 3.23M | 3.50M | 5.17M | 6.45M | 6.22M | 5.15M | 5.87M | 5.15M | 3.74M | 2.89M | 2.54M | 2.27M |
| Gross Profit | 28.21M | 11.22M | -119.08M | 9.65M | 104.42M | 56.39M | -58.55M | 77.93M | -26.33M | 5.46M | 6.78M | 8.12M | 8.03M | 7.41M | 6.48M | 7.71M | 10.54M | 5.64M | 5.73M | 4.15M | 3.31M | 1.84M |
| Gross Profit Ratio | 100.00% | 100.00% | 101.38% | 78.07% | 97.95% | 95.58% | 106.67% | 96.04% | 112.35% | 63.31% | 67.74% | 69.88% | 60.83% | 53.46% | 51.02% | 59.95% | 64.23% | 52.27% | 60.51% | 58.95% | 56.58% | 44.77% |
| Research & Development | 0.00 | 0.00 | -18.55 | 0.14 | 4.05 | 2.78 | -1.37 | 4.52 | -0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 954.29K | 2.06M | 937.21K | 969.90K | 954.90K | 1.68M | 4.20M | 2.27M | 4.02M | 4.53M | 4.76M | 4.99M | 1.77M | 1.50M | 1.72M | 1.40M | 2.08M | 1.51M | 1.33M | 1.20M | 1.22M | 1.19M |
| Selling & Marketing | 0.00 | 157.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 109.61K | 88.84K | 86.60K | 89.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 954.29K | 2.21M | 937.21K | 969.90K | 954.90K | 1.68M | 4.20M | 2.27M | -0.25 | 4.62M | 4.85M | 5.08M | 1.77M | 1.50M | 1.72M | 1.40M | 2.08M | 1.51M | 1.33M | 1.20M | 1.22M | 1.19M |
| Other Expenses | 27.26M | 0.00 | 70.43K | 60.07K | 83.82K | 160.28K | 343.29K | 231.01K | 15.72M | 35.25K | 160.00K | 50.00K | 420.00K | -320.00K | 70.00K | 100.00K | -20.00K | 10.00K | 10.00K | 0.00 | 0.00 | 10.00K |
| Operating Expenses | 28.21M | 2.21M | 1.01M | 1.03M | 1.04M | 1.84M | 4.54M | 2.50M | 5.53M | 17.07M | 17.49M | 58.98M | 2.19M | 1.18M | 1.79M | 1.50M | 2.06M | 1.52M | 1.34M | 1.20M | 1.22M | 1.20M |
| Cost & Expenses | 28.21M | 2.21M | 1.01M | 1.03M | 1.04M | 1.84M | 4.54M | 2.50M | -26.33M | 17.07M | 17.49M | 58.98M | 7.36M | 7.63M | 8.01M | 6.65M | 7.93M | 6.67M | 5.08M | 4.09M | 3.76M | 3.47M |
| Interest Income | 60.66K | 52.26K | 15.37K | 238.00 | 24.72K | 81.68K | 15.62K | 2.24K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.34M | 64.06M | 0.00 | 0.00 | 165.67M | 251.60M | 0.00 | 474.68M | 149.97M | -9.42M | 9.09M | 123.20M | ||
| Depreciation & Amortization | 0.00 | 1.13M | 570.16K | -670.93K | -675.28K | -1.56M | -2.27M | -2.88M | -7.30M | -4.00M | -5.16M | -6.54M | -100.85M | -166.23M | 331.34M | 503.20M | -885.94M | 952.77M | 299.91M | -18.72M | 18.21M | 245.68M |
| EBITDA | 0.00 | 10.13M | -118.44M | 0.00 | 105.00M | 55.88M | -59.65M | 75.68M | -1.51M | -7.39M | 22.34M | 64.06M | -95.02M | -160.00M | 336.03M | 509.41M | -877.46M | 956.89M | 304.31M | -15.77M | 20.30M | 246.32M |
| EBITDA Ratio | 0.00% | 90.31% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | 124.71% | -144.58% | 223.16% | 551.31% | -719.85% | -1,154.40% | 2,645.91% | 3,961.20% | -5,347.11% | 8,868.30% | 3,213.41% | -224.01% | 347.01% | 5,993.19% |
| Operating Income | 0.00 | 9.00M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 7.30M | 4.00M | 5.16M | 6.54M | 5.83M | 6.23M | 4.69M | 6.21M | 8.48M | 4.12M | 4.40M | 2.95M | 2.09M | 640.00K |
| Operating Income Ratio | 0.00% | 80.26% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -31.16% | 46.44% | 51.52% | 56.24% | 44.17% | 44.95% | 36.93% | 48.29% | 51.68% | 38.18% | 46.46% | 41.90% | 35.73% | 15.57% |
| Total Other Income/Expenses | 27.23M | 1.10M | -117.90M | 10.66M | 0.00 | 0.00 | 0.00 | 75.75M | -1.39M | -12.46M | -381.44K | 64.06M | -50.42M | -78.98M | -519.00 | 261.82M | -442.97M | 478.09M | 149.94M | -9.30M | 9.12M | 122.48M |
| Income Before Tax | 27.23M | 10.10M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 5.91M | -8.46M | 27.50M | 70.60M | -44.59M | -72.75M | 170.36M | 257.81M | -434.49M | 482.21M | 154.34M | -6.35M | 11.21M | 123.12M |
| Income Before Tax Ratio | 96.53% | 90.06% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -25.21% | -98.14% | 274.68% | 607.55% | -337.80% | -524.89% | 1,341.42% | 2,004.74% | -2,647.71% | 4,469.05% | 1,629.78% | -90.20% | 191.62% | 2,995.62% |
| Income Tax Expense | 0.00 | 0.00 | -601.89K | 566.17K | 566.08K | 1.27M | 216.65K | 2.97M | 5.79M | -12.46M | 22.34M | 64.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 27.23M | 10.10M | -118.47M | 11.33M | 105.57M | 57.15M | -59.44M | 78.64M | 5.79M | -8.46M | 27.50M | 70.60M | -44.59M | -72.75M | 170.36M | 257.81M | -434.49M | 482.21M | 154.34M | -6.35M | 11.21M | 123.12M |
| Net Income Ratio | 96.53% | 90.06% | 100.86% | 91.67% | 99.03% | 96.88% | 108.27% | 96.92% | -24.71% | -98.14% | 274.68% | 607.55% | -337.80% | -524.89% | 1,341.42% | 2,004.74% | -2,647.71% | 4,469.05% | 1,629.78% | -90.20% | 191.62% | 2,995.62% |
| EPS | 2.74 | 1.01 | -11.55 | 1.09 | 10.10 | 5.36 | -3.78 | 5.00 | 0.98 | -0.54 | 1.75 | 4.50 | -2.76 | -3.19 | 7.48 | 11.32 | -23.94 | 33.07 | 10.64 | -0.44 | 1.11 | 12.23 |
| EPS Diluted | 2.74 | 1.01 | -11.55 | 1.09 | 10.10 | 5.36 | -3.78 | 5.00 | 15.41M | -0.54 | 1.75 | 4.50 | -2.76 | -3.19 | 7.48 | 11.32 | -23.94 | 33.07 | 10.64 | -0.44 | 1.11 | 12.23 |
| Weighted Avg Shares Out | 9.92M | 10.03M | 10.26M | 10.37M | 10.45M | 10.66M | 15.72M | 15.72M | 5.91M | 15.68M | 15.68M | 15.68M | 16.17M | 22.78M | 22.78M | 22.78M | 18.15M | 14.58M | 14.50M | 14.39M | 10.08M | 10.07M |
| Weighted Avg Shares Out (Dil) | 9.92M | 10.03M | 10.26M | 10.37M | 10.45M | 10.66M | 15.72M | 15.73M | 0.38 | 15.68M | 15.68M | 15.68M | 16.17M | 22.78M | 22.78M | 22.78M | 18.15M | 14.58M | 14.50M | 14.39M | 10.08M | 10.07M |
China Fund: Deteriorating Chinese Economic Data Warrants Caution
China appears to be headed for more economic troubles. While the China Fund is overweight the more resilient consumer/tech side, the rest of the portfolio remains levered to broader economic shifts. With CHN's expense ratio also at a premium to...
The Month In Closed-End Funds: July 2023
For the second consecutive month, equity CEFs (+2.69% on a NAV basis) on average chalked up plus-side performance while their fixed income CEF cohorts (+1.03%) also posted gains. At month end, 13% of all CEFs traded at a premium to...
China Fund: Invest In China's Leading Platforms At A Steeper Than Usual Discount
Following a multi-year streak of relative and absolute underperformance, the Matthews Asia-managed China Fund has seen its NAV discount widen to multi-year highs. Post-reopening and with the policy backdrop for tech platforms finally turning supportive, the China Fund could outperform...
The Month In Closed-End Funds: February 2023
For the second month in three, equity CEFs (-2.68% on a NAV basis) on average witnessed negative performance. While their fixed income CEF cohorts (-1.79%) posted losses, also for the second month in three.
China Fund: Gain Exposure To The China Recovery At A Wider Than Usual Discount
China Fund offers investors an investment vehicle to gain exposure to the Chinese post-COVID reopening theme. The fund is overweight consumer discretionary and real estate, so it is particularly levered to the economic trajectory and consumer sentiment shifts.
The China Fund, Inc. Announces Date of Annual Meeting of Stockholders
BOSTON , Jan. 13, 2023 /PRNewswire/ -- The China Fund, Inc. (NYSE: CHN) (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be scheduled for Thursday, March 9, 2023, via a virtual forum at 11:00 a.m...
The Month In Closed-End Funds: November 2022
For the second month in a row, equity CEFs (+5.16% on a NAV basis) on average witnessed plus-side returns. While their fixed income CEF cohorts (+4.53%) posted gains for the first month in four.
China Fund Review: Chinese Stocks Are Not 'Uninvestable'
Uncertainty does not equal China being “uninvestable”, rather it is a potential opportunity to examine. If the odds stack up, simply make it a relatively low portfolio position. It would take some extreme events for investor sentiment towards China to...
CHN: 'Made In China' With A Discount
The China Fund is a closed end fund focused on Chinese equities. The fund has seen its discount widen substantially this year as the holdings have underperformed.
The China Fund, Inc. Announces Date of Annual Meeting of Stockholders
BOSTON, March 25, 2022 /PRNewswire/ -- The China Fund, Inc. (NYSE: CHN) (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be rescheduled for Tuesday, May 3, 2022 via a virtual forum at 11:00 a.m. Stockholders of...
Source: https://incomestatements.info
Category: Stock Reports